Charles River to Supply Pfizer's Genetically Modified Research Models

Charles River Laboratories International, Inc. CRL today announced that it has entered into a marketing and distribution agreement with Pfizer Inc. PFE to provide certain Pfizer-developed genetically modified research models to the global biomedical research community.

Under this agreement, Charles River will supply a number of pre-competitive, transgenic research models developed by Pfizer across a broad range of therapeutic areas, including neuroscience, diabetes and cardiovascular disease.